IP Library Granted Patent US 11,701,253
Granted Patent B2
US 11,701,253 · App. 17/315,542 · Granted Jul 18, 2023

Systems, devices and methods including galvanic and caloric vestibular stimulation

Inventors: Robert D. Black (Chapel Hill, NC); Lanty L. Smith (Durham, NC); Lesco L. Rogers (Raleigh, NC)
Assignee: Scion NeuroStim, Inc.
A61F7/12A61B6/037A61F7/007A61M21/02A61N1/0456A61N1/0484A61N1/0526A61N1/36021A61N1/36025A61N1/36028A61N1/36031A61N1/36034H04R1/1016H04R1/1091A61F2007/0005A61F2007/0075A61F2007/0093A61F2007/126A61M2021/0027A61M2021/0072A61M2021/0077A61M2205/054A61M2210/0662A61N1/327H04R1/10H04R2460/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,701,253
App. No.
17/315,542
Granted
Jul 18, 2023
Kind
B2
Abstract

A vestibular neurostimulation device, which may include first and second electrodes; first and second thermoelectric devices thermally coupled, respectively, to first and second earpieces that are configured to be insertable into respective ear canals of a patient; and a controller comprising a waveform generator. The waveform generator may be is configured to deliver a modulated electric signal to the patient through galvanic vestibular stimulation (GVS) using the first and second electrodes and to deliver a time varying thermal waveform to the patient through caloric vestibular stimulation (CVS) using the first and second earpieces simultaneous with the delivery of the modulated electrical signal through GVS. The CVS and/or GVS may be configured to increase a passage of insulin-like growth factor 1 (IGF-1) through a blood-brain-barrier.

Claims (32)

1. A vestibular neurostimulation device, comprising:

first and second electrodes;

first and second thermoelectric devices thermally coupled, respectively, to first and second earpieces configured to be insertable into respective ear canals of a patient; and

a controller comprising a waveform generator that is configured to deliver a modulated electric signal to the patient through galvanic vestibular stimulation (GVS) using the first and second electrodes and to deliver a time varying thermal waveform to the patient through caloric vestibular stimulation (CVS) using the first and second earpieces simultaneous with the delivery of the modulated electrical signal through GVS,

wherein the CVS and/or GVS is configured to increase a passage of insulin-like growth factor 1 (IGF-1) through a blood-brain-barrier.

2. The neurostimulation device of claim 1 , wherein the first and second earpieces comprise the first and second electrodes, respectively.

3. The neurostimulation device of claim 1 , wherein the modulated electrical signal is configured to excite different frequencies than the time varying thermal waveform.

4. The neurostimulation device of claim 3 ,

wherein the modulated electrical signal is configured to excite frequencies greater than 1 Hz, and

wherein the time varying thermal waveform is configured to excite frequencies less than 1 Hz.

5. The neurostimulation device of claim 3 , wherein the modulated electrical signal is configured to excite frequencies that are at least 10 times greater than a maximum of frequencies that the time varying thermal waveform is configured to excite.

6. The neurostimulation device of claim 1 , wherein the controller is configured to control the modulated electrical signal and the time varying thermal waveform to maintain a defined phase difference between the modulated electrical signal and the time varying thermal waveform.

7. The neurostimulation device of claim 6 , wherein the controller is configured to control the modulated electrical signal to be approximately 180° out of phase with the time varying thermal waveform.

8. The neurostimulation device of claim 1 , wherein the controller is configured to producing a net stimulation at a beat frequency equal to a difference between a frequency of the modulated electrical signal and a frequency of the time varying thermal waveform by controlling the frequency of the modulated electrical signal relative to the frequency of the time varying thermal waveform.

9. The neurostimulation device of claim 1 , wherein the CVS is configured to produce oscillations in a cerebral blood flow.

10. The neurostimulation device of claim 9 , wherein the time varying thermal waveform is configured to facilitate production of the oscillations in the cerebral blood flow.

11. The neurostimulation device of claim 10 ,

wherein the controller is configured to sequentially apply a plurality of time varying thermal waveforms, measure respective cerebral blood flow oscillations resulting from the plurality of time varying thermal waveforms, and select at least one of the plurality of time varying thermal waveforms that produces an effective amplitude of cerebral blood flow oscillations, and

wherein the controller is configured to deliver the time varying thermal waveform to the patient through CVS simultaneous with the delivery of the modulated electrical signal through GVS by delivering the selected at least one of the plurality of time varying thermal waveforms.

12. The neurostimulation device of claim 11 , wherein the modulated electrical signal is configured to activate a subset of brain regions for the increase in passage of IGF-1 through the blood-brain-barrier.

13. The neurostimulation device of claim 1 , wherein the modulated electrical signal and/or the time varying thermal waveform are configured to reduce symptoms of a neurological disease.

14. The neurostimulation device of claim 1 , wherein the modulated electrical signal and/or the time varying thermal waveform are configured to reduce symptoms of Parkinson's disease.

15. The neurostimulation device of claim 1 , wherein the modulated electrical signal and/or the time varying thermal waveform are configured to reduce symptoms of migraine headache.

16. A vestibular neurostimulation device, comprising:

first and second electrodes;

first and second thermoelectric devices thermally coupled, respectively, to first and second earpieces configured to be insertable into respective ear canals of a patient; and

a controller comprising a waveform generator that is configured to deliver a modulated electric signal to the patient through galvanic vestibular stimulation (GVS) using the first and second electrodes and to deliver a time varying thermal waveform to the patient through caloric vestibular stimulation (CVS) using the first and second earpieces simultaneous with the delivery of the modulated electrical signal through GVS,

wherein the modulated electrical signal is configured to activate a subset of brain regions for an increase in passage of insulin-like growth factor 1 (IGF-1) through a blood-brain-barrier.

17. The neurostimulation device of claim 16 , wherein the modulated electrical signal and/or the time varying thermal waveform are configured to reduce symptoms of a neurological disease.

18. The neurostimulation device of claim 16 , wherein the modulated electrical signal and/or the time varying thermal waveform are configured to reduce symptoms of Parkinson's disease.

19. The neurostimulation device of claim 16 , wherein the modulated electrical signal and/or the time varying thermal waveform are configured to reduce symptoms of migraine headache.

20. The neurostimulation device of claim 16 , wherein the CVS is configured to produce oscillations in a cerebral blood flow.

Assignments (1)
CHANGE OF NAME Recorded Jun 1, 2023
From: SCION NEUROSTIM, LLC
To: SCION NEUROSTIM, INC.
Reel/Frame 063822/0031 →
Continuity (7)
Continuation 15914516 · Mar 7, 2018
Continuation In Part PCTUS2016049824 · Sep 1, 2016
Continuation In Part PCTUS2016049827 · Sep 1, 2016
Continuation In Part PCTUS2016049836 · Sep 1, 2016
Provisional Application 62322985 · Apr 15, 2016
Provisional Application 62214474 · Sep 4, 2015
Related Publication 20210259879A1 · Aug 26, 2021
Cited By (5)
US 12,193,840 US 12,318,220 US 12,318,221 US 12,396,680 US 12,702,357